Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 964

    1.

    Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

    Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

    Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.

    PMID:
    18662380
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.

    Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C.

    Clin Cancer Res. 2008 Aug 15;14(16):5158-65.

    PMID:
    18698033
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.

    Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, He X, Palazzo JP, Olopade OI, Szabo A, Perou CM, Bernard PS.

    Breast Cancer Res. 2006;8(2):R23. Epub 2006 Apr 20.

    PMID:
    16626501
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.

    Staaf J, Ringnér M, Vallon-Christersson J, Jönsson G, Bendahl PO, Holm K, Arason A, Gunnarsson H, Hegardt C, Agnarsson BA, Luts L, Grabau D, Fernö M, Malmström PO, Johannsson OT, Loman N, Barkardottir RB, Borg A.

    J Clin Oncol. 2010 Apr 10;28(11):1813-20. Epub 2010 Mar 15.

    PMID:
    20231686
    [PubMed - indexed for MEDLINE]
    5.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.

    PMID:
    16673249
    [PubMed - indexed for MEDLINE]
    6.

    T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

    Breast Cancer Res. 2009;11(2):R15. Epub 2009 Mar 9.

    PMID:
    19272155
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.

    Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, Teschendorff AE, Mook S, van 't Veer L, Caldas C, Salmon RJ, van de Vijver MJ, Wessels LF.

    Breast Cancer Res. 2008;10(6):R93. Epub 2008 Nov 13.

    PMID:
    19014521
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

    Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO.

    J Natl Cancer Inst. 2009 May 20;101(10):736-50. Epub 2009 May 12.

    PMID:
    19436038
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.

    Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ.

    Breast Cancer Res. 2009;11(3):R27. Epub 2009 May 11.

    PMID:
    19432961
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

    Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

    J Surg Res. 2007 Nov;143(1):109-18.

    PMID:
    17950079
    [PubMed - indexed for MEDLINE]
    11.

    Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.

    Fernandes RC, Bevilacqua JL, Soares IC, Siqueira SA, Pires L, Hegg R, Carvalho FM.

    Histopathology. 2009 Sep;55(3):346-52.

    PMID:
    19723150
    [PubMed - indexed for MEDLINE]
    12.

    Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.

    Murphy NC, Biankin AV, Millar EK, McNeil CM, O'Toole SA, Segara D, Crea P, Olayioye MA, Lee CS, Fox SB, Morey AL, Christie M, Musgrove EA, Daly RJ, Lindeman GJ, Henshall SM, Visvader JE, Sutherland RL.

    Int J Cancer. 2010 Mar 15;126(6):1445-53.

    PMID:
    19676041
    [PubMed - indexed for MEDLINE]
    13.

    Comparative expression analysis of four breast cancer subtypes versus matched normal tissue from the same patients.

    Martini PG, Taylor DM, Bienkowska J, Jackson J, McAllister G, Keilhack H, Campbell RK.

    J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):207-11. Epub 2008 Mar 14.

    PMID:
    18424034
    [PubMed - indexed for MEDLINE]
    14.

    Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.

    Kammori M, Kurabayashi R, Kashio M, Sakamoto A, Yoshimoto M, Amano S, Kaminishi M, Yamada T, Takubo K.

    Oncol Rep. 2008 Mar;19(3):651-6.

    PMID:
    18288397
    [PubMed - indexed for MEDLINE]
    15.

    Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

    Sunami E, Shinozaki M, Sim MS, Nguyen SL, Vu AT, Giuliano AE, Hoon DS.

    Breast Cancer Res. 2008;10(3):R46. Epub 2008 May 16.

    PMID:
    18485221
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

    Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

    PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.

    PMID:
    19270750
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response.

    de Ronde JJ, Hannemann J, Halfwerk H, Mulder L, Straver ME, Vrancken Peeters MJ, Wesseling J, van de Vijver M, Wessels LF, Rodenhuis S.

    Breast Cancer Res Treat. 2010 Jan;119(1):119-26. Epub 2009 Aug 8.

    PMID:
    19669409
    [PubMed - indexed for MEDLINE]
    18.

    Understanding the molecular basis of histologic grade.

    Ignatiadis M, Sotiriou C.

    Pathobiology. 2008;75(2):104-11. Epub 2008 Jun 10. Review.

    PMID:
    18544965
    [PubMed - indexed for MEDLINE]
    19.

    Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

    Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF.

    Clin Cancer Res. 2003 Jul;9(7):2406-15.

    PMID:
    12855612
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

    Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.

    PLoS One. 2009 Jul 3;4(7):e6146.

    PMID:
    19582160
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk